Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy Reau

Showing results (71-80 of 99) with videos related to

Pageof 10
Sort By:
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 9, 2023
Precipitous changes in nomenclature and definitions-NAFLD becomes SLD: Implications for and expectations of AASLD journalsHarmeet Malhi, Robert S Brown, Joseph K Lim, et al.
Hepatology Communications|November 9, 2023
Precipitous changes in nomenclature and definitions-NAFLD becomes SLD: Implications for and expectations of AASLD journalsHarmeet Malhi, Robert S Brown, Joseph K Lim, et al.
Hepatology (Baltimore, Md.)|November 9, 2023
Precipitous changes in nomenclature and definitions-NAFLD becomes SLD: Implications for and expectations of AASLD journalsHarmeet Malhi, Robert S Brown, Joseph K Lim, et al.
Hepatology (Baltimore, Md.)|April 1, 2022
An international survey on patterns of practice in NAFLD and expectations for therapies-The POP-NEXT projectVlad Ratziu, Quentin M Anstee, Vincent Wai-Sun Wong, et al.
Blood Advances|July 15, 2022
Liver fibrosis and its response to avapritinib in 2 patients with systemic mastocytosisKarla Cavazos, Sheila Eswaran, Cathleen Maidlow, et al.
The American Journal of Gastroenterology|April 6, 2016
Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir Plus Dasabuvir With or Without Ribavirin in HCV-Infected Patients Taking Concomitant Acid-Reducing AgentsMitchell L Shiffman, Vinod Rustgi, Michael Bennett, et al.
The American Journal of Gastroenterology|July 1, 2016
Corrigendum: Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir Plus Dasabuvir With or Without Ribavirin in HCV-Infected Patients Taking Concomitant Acid-Reducing AgentsMitchell L Shiffman, Vinod Rustgi, Michael Bennett, et al.
Hepatology (Baltimore, Md.)|August 11, 2016
Novel educational interventions in residency increase knowledge of chronic liver disease and career interest in hepatologyAdam E Mikolajczyk, Jeanne M Farnan, John F McConville, et al.
Journal of Patient-Reported Outcomes|July 7, 2025
Exploring the patient experience of chronic hepatitis D (CHD) and assessment of content validity of the Hepatitis Quality of Life Questionnaire and (HQLQv2) and the Fatigue Severity Scale (FSS)Pietro Lampertico, Aishwarya Chohan, Hannah Elwick, et al.
Viruses|February 27, 2026
Predictive Value of Sustained Virologic Response at Week 4 in Patients with Hepatitis C Virus Infection Treated with Sofosbuvir/VelpatasvirGia Landry, Mark Sulkowski, Jordan J Feld, et al.
Pageof 10

Showing results (71-80 of 99) with videos related to

Sort By:
Pageof 10
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 9, 2023
Precipitous changes in nomenclature and definitions-NAFLD becomes SLD: Implications for and expectations of AASLD journalsHarmeet Malhi, Robert S Brown, Joseph K Lim, et al.
Hepatology Communications|November 9, 2023
Precipitous changes in nomenclature and definitions-NAFLD becomes SLD: Implications for and expectations of AASLD journalsHarmeet Malhi, Robert S Brown, Joseph K Lim, et al.
Hepatology (Baltimore, Md.)|November 9, 2023
Precipitous changes in nomenclature and definitions-NAFLD becomes SLD: Implications for and expectations of AASLD journalsHarmeet Malhi, Robert S Brown, Joseph K Lim, et al.
Hepatology (Baltimore, Md.)|April 1, 2022
An international survey on patterns of practice in NAFLD and expectations for therapies-The POP-NEXT projectVlad Ratziu, Quentin M Anstee, Vincent Wai-Sun Wong, et al.
Blood Advances|July 15, 2022
Liver fibrosis and its response to avapritinib in 2 patients with systemic mastocytosisKarla Cavazos, Sheila Eswaran, Cathleen Maidlow, et al.
The American Journal of Gastroenterology|April 6, 2016
Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir Plus Dasabuvir With or Without Ribavirin in HCV-Infected Patients Taking Concomitant Acid-Reducing AgentsMitchell L Shiffman, Vinod Rustgi, Michael Bennett, et al.
The American Journal of Gastroenterology|July 1, 2016
Corrigendum: Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir Plus Dasabuvir With or Without Ribavirin in HCV-Infected Patients Taking Concomitant Acid-Reducing AgentsMitchell L Shiffman, Vinod Rustgi, Michael Bennett, et al.
Hepatology (Baltimore, Md.)|August 11, 2016
Novel educational interventions in residency increase knowledge of chronic liver disease and career interest in hepatologyAdam E Mikolajczyk, Jeanne M Farnan, John F McConville, et al.
Journal of Patient-Reported Outcomes|July 7, 2025
Exploring the patient experience of chronic hepatitis D (CHD) and assessment of content validity of the Hepatitis Quality of Life Questionnaire and (HQLQv2) and the Fatigue Severity Scale (FSS)Pietro Lampertico, Aishwarya Chohan, Hannah Elwick, et al.
Viruses|February 27, 2026
Predictive Value of Sustained Virologic Response at Week 4 in Patients with Hepatitis C Virus Infection Treated with Sofosbuvir/VelpatasvirGia Landry, Mark Sulkowski, Jordan J Feld, et al.
Pageof 10